62 related articles for article (PubMed ID: 9026033)
1. Influence of endosome-destabilizing peptides on efficacy of anti-HIV immunotoxins.
Tolstikov VV; Cole R; Fang H; Pincus SH
Bioconjug Chem; 1997; 8(1):38-43. PubMed ID: 9026033
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.
Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220
[TBL] [Abstract][Full Text] [Related]
3. Arrest of endosome acidification by bafilomycin A1 mimics insulin action on GLUT4 translocation in 3T3-L1 adipocytes.
Chinni SR; Shisheva A
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):599-606. PubMed ID: 10215598
[TBL] [Abstract][Full Text] [Related]
4. Microtubules are involved in bafilomycin A1-induced tubulation and Rab5-dependent vacuolation of early endosomes.
D'Arrigo A; Bucci C; Toh BH; Stenmark H
Eur J Cell Biol; 1997 Feb; 72(2):95-103. PubMed ID: 9157016
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
[TBL] [Abstract][Full Text] [Related]
6. Selective killing of HIV-infected cells by anti-gp120 immunotoxins.
Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):193-203. PubMed ID: 2328157
[TBL] [Abstract][Full Text] [Related]
7. The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus.
Glomb-Reinmund S; Kielian M
Virology; 1998 Sep; 248(2):372-81. PubMed ID: 9721245
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
Neurath AR; Strick N; Debnath AK
J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection.
Pincus SH; Fang H; Wilkinson RA; Marcotte TK; Robinson JE; Olson WC
J Immunol; 2003 Feb; 170(4):2236-41. PubMed ID: 12574398
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of acylated and telomerized peptides as potential HIV-fixation inhibitors.
Lacoux X; Barragan V; Dewynter G; Leydet A; Roque JP; Montero JL
Farmaco; 1996 Dec; 51(12):767-73. PubMed ID: 9050208
[TBL] [Abstract][Full Text] [Related]
11. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
12. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
13. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
14. Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells.
Choo AB; Dunn RD; Broady KW; Raison RL
Protein Expr Purif; 2002 Apr; 24(3):338-47. PubMed ID: 11922749
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
Gorny MK; VanCott TC; Hioe C; Israel ZR; Michael NL; Conley AJ; Williams C; Kessler JA; Chigurupati P; Burda S; Zolla-Pazner S
J Immunol; 1997 Nov; 159(10):5114-22. PubMed ID: 9366441
[TBL] [Abstract][Full Text] [Related]
17. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.
Luo T; Douglas JL; Livingston RL; Garcia JV
Virology; 1998 Feb; 241(2):224-33. PubMed ID: 9499797
[TBL] [Abstract][Full Text] [Related]
18. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Zvi A; Feigelson DJ; Hayek Y; Anglister J
Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
[TBL] [Abstract][Full Text] [Related]
19. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1.
Ohta T; Arakawa H; Futagami F; Fushida S; Kitagawa H; Kayahara M; Nagakawa T; Miwa K; Kurashima K; Numata M; Kitamura Y; Terada T; Ohkuma S
J Pathol; 1998 Jul; 185(3):324-30. PubMed ID: 9771488
[TBL] [Abstract][Full Text] [Related]
20. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
